The regulation of heart failure (HF) is complex and under the control of different physiological systems. Abnormalities of Ca^2+^ homeostasis is known to occur within cardiac myocytes in a wide variety of heart disease, including HF. It is noted that the mRNA abundance of sarcolemmal (SL) Na^+^/Ca^2+^ exchange, sarcoplasmic reticular (SR) ryanodine receptor, and SR Ca^2+^-ATPase are all decreased in response to stimulation by angiotensin in neonatal myocytes[@b1]. Angiotensinogen (AGT), a globular glycoprotein in the renin-angiotensin-aldosterone system (RAAS), is encoded by the AGT gene and located on chromosome 1q42[@b2]. AGT is produced by the liver and changed to angiotensin I via renin. After-wards, angiotensin I is converted to angiotensin II, and the elevated cardiac angiotensin II levels alone do not directly induce cardiac hypertrophy but do increase interstitial fibrosis[@b3]. A M235T (rs699) polymorphism, encoding a threonine instead of a methionine at residue 235 of the mature protein, has been associated with higher plasma AGT levels among patients with the T allele[@b4].

HF is an ever increasing problem worldwide and is a major health problem associated with very high morbidity and mortality[@b5]. Coronary heart disease and hypertension are major causes of HF; other underlying conditions include idiopathic dilated cardiomyopathy (IDC), valvular congenital heart disease, and diabetes mellitus. It is difficult to predict who will develop heart failure in response to myocardial injury[@b6]. Although the exact molecular mechanisms of HF are still under intensive investigation, genetic polymorphisms of major neurohormonal systems involved in the pathophysiology of HF have been discussed[@b7].

Over the last ten years, a number of molecular epidemiological studies have been conducted to investigate the association between the AGT M235T polymorphism and HF risk, but the results remain inconsistent. In addition, a previous meta-analysis on this issue also generated conflicting results[@b8]. To assess the association of AGT M235T polymorphism with the risk of HF, we conducted a meta-analysis from all eligible case-control studies published to data.

Results
=======

Characteristics of studies
--------------------------

There were 57 published papers relevant to the search words. Based on the inclusion criteria, only six case-control studies were selected for this meta-analysis \[9--26\], and 41 studies were excluded. The flow chart of the study selection is summarized in [Fig. 1](#f1){ref-type="fig"}. These selected studies included 1,281 cases and 1,376 control subjects. All studies were case-control studies that evaluated the association between the AGT M235T polymorphism and HF risk[@b9][@b10][@b11][@b12][@b13][@b14]. The distribution of genotypes in the controls of each study was in agreement with Hardy-Weinberg equilibrium except for one study[@b9]. Of these case-control studies, three reported on Europeans, while three reports were on Asians ([](#t1){ref-type="table"}[Table 2](#t2){ref-type="table"}).

Main results
------------

The fixed- and random-effects models were used to pool the results ([Table 3](#t3){ref-type="table"}). There was no evidence that the AGT M235T polymorphism was associated with HF risk in all genetic models (TT vs. MM, OR = 1.17, 95%CI = 0.62--2.19; MT vs. MM, OR = 0.97, 95%CI = 0.77--1.22; MT/TT vs. MM, OR = 1.07, 95%CI = 0.67--1.69; and TT vs. MM/MT, OR = 1.23, 95%CI = 0.86--1.76, [Fig. 2](#f2){ref-type="fig"}). In contrast, in the subgroup analysis by ethnicity, significantly decreased risk of HF was detected among Asians for MT vs. MM (OR = 0.39, 95%CI = 0.17--0.92, [Table 3](#t3){ref-type="table"}).

Heterogeneity and sensitivity analyses
--------------------------------------

Significant heterogeneity between studies was observed in overall comparisons except for MT vs. MM model (*P*~heterogeneity~ = 0.087). The results revealed that no individual study significantly affect the pooled ORs, indicating that our results were statistically robust.

Publication bias
----------------

Egger\'s test provided no evidence for funnel plot asymmetry in the AGT M235T polymorphism in overall comparisons (t = −0.67, *P* = 0.541 for TT vs. MM/MT). [Figure 3](#f3){ref-type="fig"} showed the Begg\'s funnel plot on Egger\'s test.

Discussion
==========

This meta-analysis explored all available data on the association between the AGT M235T polymorphism and HF risk, including a total of 1,281 HF cases and 1,376 controls. We found that the variant MT genotype was associated with significant decreased risk of HF among Asians. Given the important roles of AGT in the regulation of RAS, it is biologically plausible that AGT polymorphism may modulate the risk of HF.

The RAAS plays an important role in the pathogenesis of HF. Following cleavage of AGT into angiotensin I by renin, production of biologically active Ang II causes vasoconstriction, stimulates sodium reabsorption[@b15]. The combinations of these abnormalities, myocardial fibrosis, and other factors modulated by RASS pathways are likely to lead to HF. The AGT gene has been widely researched as a HF candidate gene. Ishanov et al. firstly found a higher frequency of the 235T allele in hypertrophic cardiomyopathy[@b16]. The same significant association was observed in the Czech Republic women[@b12]. The results of our meta-analysis were consistent with these experimental findings. However, the effect of the AGT M235T polymorphism is still unclear. Yamada et al. indicated that there was no association between the AGT M235T polymorphism and HF risk[@b10]. Therefore, the function of the AGT M235T polymorphism needs to clarify clearly in the further.

In the subgroup analysis by ethnicity, there was a significant association found among Asians, but not Europeans, suggesting a possible role of ethnic differences in genetic backgrounds and the environment they live in. Furthermore, according to the etiology of the left ventricular dysfunction, HF can be classified with ischemic heart disease and dilated cardiomyopathy[@b17]. However, most studies did not include the analysis with these classifications. Therefore, further studies with different classifications of HF are needed to validate our findings. Although our results are not fully accord with previous meta-analysis regarding the positive association for the AGT M235T polymorphism[@b8], we have made much more stable and detailed analysis to support our findings, which made our results much more reliable compared with previous meta-analysis, because we included more studies to improve the statistical power.

The present meta-analysis has some advantages compared to other individual studies; however, it does have some limitations. Firstly, the effect of genetic and environmental interactions was not addressed in our meta-analysis. Secondly, the results of subgroup analysis should be interpreted with caution because of limited statistical power. Thirdly, several studies have suggested that A-6G, A-20C and G-217A polymorphisms in the promoter region of AGT are implicated in the regulation of AGT gene transcription and expression, which may have an interaction with the M235T polymorphism[@b18]. However, given the limited evidence available on other AGT polymorphisms, this meta-analysis was restricted to the M235T polymorphism because it has been the most frequently studied. Therefore, we could not assess the haplotype effect on the risk of HF.

Taken together, the present meta-analysis suggests that the AGT M235T polymorphism may be involved in the risk of HF. Further large well-designed studies are still needed to determine the effects of the AGT M235T polymorphisms on HF.

Methods
=======

Selection of relevant studies
-----------------------------

A comprehensive search was conducted to identify for all relevant studies before August 10, 2013, using the search terms "angiotensinogen," "polymorphism," and "heart failure" in PubMed and China Biology Medicine (CBM) databases. Case reports, corresponding to editor, and review articles were excluded. The references cited in retrieved articles were also screened. Eligible studies included in the meta-analysis met the following criteria: (1) studies were conducted to have the evaluation of AGT M235T polymorphism and HF risk, (2) an unrelated case-control study, and (3) have available genotype frequency.

Data extraction
---------------

Two investigators independently extracted the data and reached consensus on all items. Data were collected on first author, year of publication, ethnicity of study population, quality scores, numbers of genotyped cases and controls, and Hardy-Weinberg equilibrium (HWE) of controls. Different ethnic descents were categorized as European, African, and Asian. Quality of studies was assessed according to the predefined criteria based on previous meta-analyses of observational studies[@b19][@b20] ([Table 1](#t1){ref-type="table"}).

Statistical analysis
--------------------

The strength of the associations between the AGT M235T polymorphism and HF risk was estimated by the crude odds ratios (ORs) with 95% confidence intervals (CIs). We first estimated the risk of the variant genotype TT vs. MM, and MT vs. MM, and then evaluated the dominant model (MT/TT vs. MM), and recessive model (TT vs. MM/MT). A Q-test was performed to assess the between-study heterogeneity[@b21]. Heterogeneity was considered significant if the *P* \< 0.05 among studies, and the summary OR estimate of each study was calculated by the fixed-effects model. Otherwise, the random-effects model was used. Publication bias was invested by funnel plot, in which the standard error of log (OR) of each study was plotted against its OR. Funnel plots were assessed by the method of Egger\'s linear regression test. Subgroup analysis was performed according to ethnicity. Sensitivity analysis was performed by sequential omission of individual studies to ensure the stability of measuring results. All analyses were performed using the Stata software (version 10.0 StataCorp LP, College Station, TX). All *P* values were two-sided.
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###### Quality assessment in the meta-analysis

  Criteria                                                                               Score
  ------------------------------------------------------------------------------------- -------
  A. Representativeness of cases                                                            
  Selected from population or hospital                                                     2
  Selected from any cardiovascular diseases service                                        1
  Selected without clearly defined inclusion/exclusion criteria                            0
  B. Credibility of controls                                                                
  Population-based                                                                         3
  Blood donors or volunteers                                                               2
  Hospital-based                                                                           1
  Not described                                                                            0
  C. Ascertainment of heart failure                                                         
  Two doctors confirmed                                                                    2
  Diagnosis of heart failure by patient medical record                                     1
  Not described                                                                            0
  D. Genotyping examination                                                                 
  Genotyping done under blinded condition                                                  1
  Not mentioned                                                                            0
  E. Hardy-Weinberg equilibrium                                                             
  Equilibrium in controls                                                                  2
  Disequilibrium in controls                                                               1
  No checked                                                                               0
  F. Association assessment                                                                 
  Assess association between genotypes and heart failure with appropriate statistics       2
  Assess association between genotypes and colorectal cancer with logistic regression      1
  Inappropriate statistics used                                                            0

###### Study characteristics in the meta-analysis

  First author           Publication year      Country       Ethnicity   Sample size (cases/controls)   MAF[b](#t2-fn2){ref-type="fn"}   Quality scores   *P* [a](#t2-fn1){ref-type="fn"}
  --------------------- ------------------ ---------------- ----------- ------------------------------ -------------------------------- ---------------- ---------------------------------
  Yamada                       1997             Japan          Asian               159/122                          0.197                      6                       0.119
  Tiret                        2000             France       European              428/398                          0.426                      7                       0.969
  Tiago                        2002             Africa        African              157/225                          0.129                      6                       0.026
  Goldbergova                  2003         Czech Republic   European              158/200                          0.435                      8                       0.808
  Peng                         2006             China          Asian               111/110                          0.223                      7                       0.176
  Zakrzewski-Jakubiak          2007             Canada       European               58/111                          0.316                      6                       0.649
  Wu                           2009             China          Asian               210/210                          0.138                      9                       0.998

^a^*P* value of Hardy-Weinberg equilibrium test.

^b^MAF, minor allele frequency in controls.

###### Meta-analysis of the AGT M235T polymorphism on HF risk

                                      TT vs. MM                     MT vs. MM   MT/TT vs. MM (dominant)   TT vs. MM/MT (recessive)                                                                                                        
  ------------- --- ---------------------------------------------- ----------- ------------------------- -------------------------- ---------------------------------------------- ------- ---------------------------------------------- -------
  Total          7   1.17 (0.62--2.19)[c](#t3-fn3){ref-type="fn"}     0.012        0.97 (0.77--1.22)               0.087             1.07 (0.67--1.69)[c](#t3-fn3){ref-type="fn"}   0.035   1.23 (0.86--1.76)[c](#t3-fn3){ref-type="fn"}   0.002
  Ethnicities                                                                                                                                                                                                                                 
  Asian          3                0.62 (0.27--1.45)                   0.467        0.39 (0.17--0.92)               0.873                          0.54 (0.24--1.22)                 0.543                1.39 (0.83--2.33)                 0.044
  European       3   1.66 (0.70--3.92)[c](#t3-fn3){ref-type="fn"}     0.004        1.05 (0.82--1.33)               0.086             1.31 (0.76--2.28)[c](#t3-fn3){ref-type="fn"}   0.014                1.40 (0.77--2.58)                 0.026

^a^Number of comparisons.

^b^*P* value of Q-test for heterogeneity test.

^c^Random-effects model was used when *P* value for heterogeneity test \<0.05; otherwise, fix-effects model was used.
